Prognostic Stage III Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Dostarlimab (DB15627)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Recruiting1 IdentifierTitlePurposeDrugs
NCT04673448Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal CancerTreatment